HAIKOU, Hainan, China, Sept. 1 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (BULLETIN BOARD: CPHI) which develops, manufactures, and markets generic and branded bio/pharmaceutical products in China, today announced attendance at the Susquehanna Financial Group, LLP (SIG)"Beijing Management Summit" held in Beijing, PRC, from the 10th to the 12th of September 2008.
Attending this conference and available for one-on-one meetings with analysts and investors throughout the conference will be senior management from the company including the President and CEO, Ms Zhilin Li, and the CFO, Mr Xinhua Wu.
Ms Zhilin Li has been CEO of China Pharma since 2005. She also founded and has been CEO of Hainan Helpson Medicine & Biotechnique Ltd. (Helpson; a wholly owned subsidiary of China Pharma Holdings, Inc.) since 1993. Mr Xinhua Wu has been CFO of Helpson since 1999 and CFO of China Pharma since 2005.
Management will discuss the Company's current product portfolio, development pipeline, research and development platform, recent financial highlights and growth strategy.
For more information on the conference, please visit the SIG website. About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. develops, manufactures, and markets generic and brand bio/pharmaceutical products in China that treat a wide range of conditions, including infections, liver disease, cardio/cerebrovascular and CNS diseases, and other prevalent diseases.
Helpson is a specialty pharmaceutical company headquartered in Haikou City, Hainan Province, China.
For more information, please contact:
Diana
China Pharma Holdings, Inc.
Tel: +86-898-6681-1730
Fax: +86-898-6681-9024
Email:
